{"product_id":"fundamentals-of-molecular-virology-isbn-9781119885863","title":"Fundamentals of Molecular Virology","description":"\u003cp\u003e\u003cb\u003eComprehensive coverage of major families of viruses, including human pathogens and viruses of organisms from bacteria to plants, with updated information on antiviral drugs, vaccines, antiviral immunity, and gene therapy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eFundamentals of Molecular Virology\u003c\/i\u003e is a textbook designed for university students learning about viruses at the undergraduate or graduate levels. Chapters contributed by prominent virologists cover many of the major virus families. Each chapter is designed to tell a story about the viruses covered, including information on discovery, diseases and pathogenesis, virus structure, steps in replication, and interaction with cellular signaling pathways. This approach portrays the \"personality\" of each virus, helping students to learn the material and build up their knowledge of virology starting with smaller and simpler viruses and proceeding to more complex viruses.\u003c\/p\u003e \u003cp\u003eMajor importance is given to viruses that infect humans and cause disease, but coverage is broad, including viruses of bacteria, Archaea, algae, invertebrates, and plants. Information boxes highlight applications and research directions of particular significance. Chapters conclude with sections presenting fundamental concepts, review questions, and lists of key terms, which are defined in a glossary at the end of the book.\u003c\/p\u003e \u003cp\u003eThis 3rd edition of \u003ci\u003eFundamentals of Molecular Virology\u003c\/i\u003e includes detailed information on the recent COVID-19 pandemic and mRNA vaccine technology, additional sections on pathogenic herpesviruses, and updates on recent outbreaks of Zika virus, Ebola virus and mpox diseases. New chapters describe hepatitis C virus, rhabdoviruses, viruses of invertebrates, oncolytic viruses, and virus-mediated gene therapy. All chapters, including those on innate and adaptive immune responses to virus infections, virus vaccines, and antiviral agents, were revised and updated.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection I: Introduction To Virology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1. Introduction to Virology 2\u003cbr\u003e \u003ci\u003eNicholas H. Acheson, McGill University Christopher D. Richardson, Dalhousie University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2. Virus Structure and Assembly 19\u003cbr\u003e \u003ci\u003eStephen C. Harrison, Harvard University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3. Virus Classification: The World of Viruses 32\u003cbr\u003e \u003ci\u003eNicholas H. Acheson, McGill University Christopher D. Richardson, Dalhousie University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4. Virus Entry 47\u003cbr\u003e \u003ci\u003eAri Helenius, Swiss Federal Institute of Technology, Zurich\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection II: Viruses of Bacteria And Archaea\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e5. Single-Stranded RNA Bacteriophages 60\u003cbr\u003e \u003ci\u003eJan van Duin, University of Leiden Karthik Chamakura, Armata Pharmaceuticals, Inc., Los Angeles Ryland Young, Texas A\u0026amp;M University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6. Microviruses 74\u003cbr\u003e \u003ci\u003eBentley A. Fane, University of Arizona Aaron P. Roznowski, University of Arizona\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7. Bacteriophage T7 84\u003cbr\u003e \u003ci\u003eWilliam C. Summers, Yale University Ian J. Molineux, University of Texas, Austin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8. Bacteriophage T4 94\u003cbr\u003e \u003ci\u003eDeborah M. Hinton, National Institutes of Health, Bethesda Eric S. Miller, North Carolina State University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9. Bacteriophage Lambda 110\u003cbr\u003e \u003ci\u003eMichael Feiss, University of Iowa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10. Viruses of Archaea 123\u003cbr\u003e \u003ci\u003eDavid Prangishvili, Institut Pasteur, Paris Mart Krupovic, Institut Pasteur, Paris\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection III: Positive-Strand Rna Animal Viruses\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e11. Picornaviruses 140\u003cbr\u003e \u003ci\u003eBert L. Semler, University of California, Irvine\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12. Flaviviruses 152\u003cbr\u003e \u003ci\u003eRichard Kuhn, Purdue University Shelton Bradrick, Trudeau Institute, New York\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13. Hepaciviruses 164\u003cbr\u003e \u003ci\u003eJohn Lok Man Law, Memorial University of Newfoundland Michael Houghton, University of Alberta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14. Togaviruses and Rubella Virus 178\u003cbr\u003e \u003ci\u003eAnil Kumar, University of Saskatchewan Milton Schlesinger, Washington University, St. Louis Sondra Schlesinger, Washington University, St. Louis Tom C. Hobman, University of Alberta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15. Coronaviruses 192\u003cbr\u003e \u003ci\u003eMarc Desforges, Ste. Justine Hospital, Université de Montréal Pierre Talbot, Institut Armand-Frappier Mark Denison, Vanderbilt University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection IV: Negative-Strand and Double-Stranded Rna Animal Viruses\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e16. Paramyxoviruses and Pneumoviruses 210\u003cbr\u003e \u003ci\u003eCopyrighted Material Nicholas H. Acheson, McGill University Daniel Kolakofsky, University of Geneva Laurent Roux, University of Geneva Christopher D. Richardson, Dalhousie University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17. Rhabdoviruses 226\u003cbr\u003e \u003ci\u003eValery Grdzelishvili, University of North Carolina, Charlotte Cassandra A. Catacalos, University of North Carolina, Charlotte\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18. Filoviruses 237\u003cbr\u003e \u003ci\u003eHeinz Feldmann, Rocky Mountain Laboratories, Montana Hans-Dieter Klenk, University of Marburg Nicholas H. Acheson, McGill University Angela Rasmussen, University of Saskatchewan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19. Bunyaviruses 251\u003cbr\u003e \u003ci\u003eRichard M. Elliott, University of Glasgow Lev Levanov, University of Helsinki Alexander Plyusnin, University of Helsinki\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20. Influenza Viruses 262\u003cbr\u003e \u003ci\u003eDalius J. Briedis, McGill University Alyson Kelvin, University of Calgary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21. Reoviruses 278\u003cbr\u003e \u003ci\u003eKristen M. Ogden, Vanderbilt University Terence S. Dermody, University of Pittsburgh School of Medicine\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection V: Small Dna Animal Viruses\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e22. Parvoviruses 292\u003cbr\u003e \u003ci\u003ePeter Beard, École Polytechnique Fédérale de Lausanne Sarah Wootton, University of Guelph\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23. Polyomaviruses 302\u003cbr\u003e \u003ci\u003eNicholas H. Acheson, McGill University James A. DeCaprio, Dana-Farber Cancer Institute, Harvard University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24. Papillomaviruses 318\u003cbr\u003e \u003ci\u003eGreg Matlashewski, McGill University Lawrence Banks, International Centre for Genetic Engineering and Biotechnology, Trieste Miranda Thomas, International Centre for Genetic Engineering and Biotechnology, Trieste\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VI: Large Dna Animal Viruses\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e25. Adenoviruses 330\u003cbr\u003e \u003ci\u003ePhilip Branton, McGill University Richard C. Marcellus, McGill University Luca D. Bertzbach, Leibniz Institute of Virology, Hamburg Thomas Dobner, Leibniz Institute of Virology, Hamburg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26. Herpesviruses 344\u003cbr\u003e \u003ci\u003eBernard Roizman, University of Chicago Gabriella Campadelli-Fiume, University of Bologna Richard Longnecker, Northwestern University Bruce Banfield, Queens University Craig McCormick, Dalhousie University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27. Poxviruses 366\u003cbr\u003e \u003ci\u003eRichard Condit, University of Florida Matthew D. Gresseth, Medical University of South Carolina Paula Traktman, Medical University of South Carolina\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VII: Viruses with a Reverse Transcriptase\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e28. Retroviruses 382\u003cbr\u003e \u003ci\u003eAlan Cochrane, University of Toronto\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29. Human Immunodeficiency Virus 394\u003cbr\u003e \u003ci\u003eAlan Cochrane, University of Toronto\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30. Hepadnaviruses 406\u003cbr\u003e \u003ci\u003eChristopher D. Richardson, Dalhousie University William Addison, University of Alberta D. Lorne Tyrrell, University of Alberta\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection VIII: Viroids and Prions\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31. Viroids and Hepatitis Delta Virus 420\u003cbr\u003e \u003ci\u003eJean-Pierre Perreault, Université de Sherbrooke Martin Pelchat, University of Ottawa Charith Raj Adkar-Purushothama, Université de Sherbrooke\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32. Prions 431\u003cbr\u003e \u003ci\u003eDalius J. Briedis, McGill University David Westaway, University of California, San Francisco\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection IX: Viruses of Plants, Algae, And Invertebrates\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e33. Cucumber Mosaic Virus 444\u003cbr\u003e \u003ci\u003eMarilyn J. Roossinck, Pennsylvania State College of Agricultural Sciences\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34. Viruses of Algae and Mimivirus, a Giant Virus 457\u003cbr\u003e \u003ci\u003eMichael J. Allen, University of Exeter William H. Wilson, Marine Biological Association, Plymouth John A. Duffy, University of Exeter\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35. Baculoviruses 478\u003cbr\u003e \u003ci\u003eEric Carstens, Queens University Robert L. Harrison, U.S. Department of Agriculture, Beltsville, Maryland\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36. Viruses of Invertebrates 489\u003cbr\u003e \u003ci\u003ePeter Krell, University of Guelph\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection X: Host Defenses Against Virus Infection\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e37. Innate Immune Responses Against Virus Infection 506\u003cbr\u003e \u003ci\u003eKaren Mossman, McMaster University John Hiscott, Istituto Pasteur-Fondazione Cenci Bolognetti, Rome Alessandra Zevini, Istituto Pasteur-Fondazione Cenci Bolognetti, Rome\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38. Adaptive Immune Responses to Virus Infection 527\u003cbr\u003e \u003ci\u003eMalcolm G. Baines, McGill University Karen Mossman, McMaster University Naglaa Shoukry, University of Montreal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection XI: Medical Applications of Virology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e39. Antiviral Vaccines 542\u003cbr\u003e \u003ci\u003eBrian Ward, McGill University Hilary E. Hendin, McGill University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40. Antiviral Chemotherapy 562\u003cbr\u003e \u003ci\u003eDonald M. Coen, Harvard Medical School\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41. Oncolytic Viruses 578\u003cbr\u003e \u003ci\u003eVishnupriyan Kumar, Dalhousie University Liang-Tzung Lin, Taipei Medical University Shashi Gujar, Dalhousie University\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42. Virus-Mediated Gene Therapy 586\u003cbr\u003e \u003ci\u003eRichard Peluso, Renovacor, Philadelphia Christopher D. Richardson, Dalhousie University\u003c\/i\u003e\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eChristopher D. Richardson\u003c\/b\u003e is Professor, Department of Microbiology \u0026amp; Immunology, Department of Pediatrics, Dalhousie University, Canada. Dr. Chris Richardson is a molecular virologist with 35 years of experience working with a variety of viruses. He earned his PhD at the University of British Columbia and did postdoctoral work at The Rockefeller University and the National Institutes of Health (Bethesda, USA). He previously held faculty positions at the National Research Council of Canada, McGill University, and the University of Toronto. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eNicholas H. Acheson\u003c\/b\u003e is Emeritus Professor of Microbiology \u0026amp; Immunology at McGill University, Quebec, Canada. He earned his PhD from The Rockefeller University and was a postdoctoral fellow at the Swiss Institute for Experimental Cancer Research (Lausanne) and Institut Pasteur (Paris). He carried out research on Semliki Forest virus and mouse polyomavirus, and taught a virology course for advanced undergraduate students at McGill University.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eComprehensive coverage of major families of viruses, including human pathogens and viruses of organisms from bacteria to plants, with updated information on antiviral drugs, vaccines, antiviral immunity, and gene therapy\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003e\u003ci\u003eFundamentals of Molecular Virology\u003c\/i\u003e is a textbook designed for university students learning about viruses at the undergraduate or graduate levels. Chapters contributed by prominent virologists cover many of the major virus families. Each chapter is designed to tell a story about the viruses covered, including information on discovery, diseases and pathogenesis, virus structure, steps in replication, and interaction with cellular signaling pathways. This approach portrays the “personality” of each virus, helping students to learn the material and build up their knowledge of virology starting with smaller and simpler viruses and proceeding to more complex viruses. \u003c\/p\u003e\u003cp\u003eMajor importance is given to viruses that infect humans and cause disease, but coverage is broad, including viruses of bacteria, Archaea, algae, invertebrates, and plants. Information boxes highlight applications and research directions of particular significance. Chapters conclude with sections presenting fundamental concepts, review questions, and lists of key terms, which are defined in a glossary at the end of the book. \u003c\/p\u003e\u003cp\u003eThis 3rd edition of \u003ci\u003eFundamentals of Molecular Virology\u003c\/i\u003e includes detailed information on the recent COVID-19 pandemic and mRNA vaccine technology, additional sections on pathogenic herpesviruses, and updates on recent outbreaks of Zika virus, Ebola virus and mpox diseases. New chapters describe hepatitis C virus, rhabdoviruses, viruses of invertebrates, oncolytic viruses, and virus-mediated gene therapy. All chapters, including those on innate and adaptive immune responses to virus infections, virus vaccines, and antiviral agents, were revised and updated.\u003c\/p\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":47989261762789,"sku":"NP9781119885863","price":111.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119885863.jpg?v=1761783424","url":"https:\/\/k12savings.com\/es\/products\/fundamentals-of-molecular-virology-isbn-9781119885863","provider":"K12savings","version":"1.0","type":"link"}